Influence-Tools/republic-os
1
0
Fork 0
Code Issues Pull Requests Actions Packages Projects Releases Wiki Activity
Files
main
republic-os/legislation/us/states/ky/2026rs/sb-77.md
T
Fabio 5941153bb7 Legislation: batch B — IL IN KS KY LA MA MD ME MI MN 
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
2026-07-06 17:27:20 -04:00

6.8 KiB
Raw Permalink Blame History

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
type title description jurisdiction legislature session identifier citation classification subjects status primary_sponsors version_count action_count vote_count first_action last_action source source_identifier source_url source_hash vintage source_snapshot retrieved_at confidence tags
Bill AN ACT relating to ibogaine research in the Commonwealth. Create new sections of KRS Chapter 218A to define terms; establish the ibogaine research and intellectual property fund to be administered by the Department of Agriculture for the purpose of allowing the department to enter a public-private partnership with a drug developer to conduct a clinical drug development trial or trials related to the use of ibogaine for the treatment of opioid use disorder, co-occurring substance use disorder, or any other neurological or mental health condition for which ibogaine demonstrates efficacy; establish requirements for the department related to how it contracts with a drug developer related to ibogaine research and intellectual property; appropriate $21 million from the opioid abatement trust fund to the ibogaine research and intellectual property development fund in fiscal year 2026-2027 and in fiscal year 2027-2028; APPROPRIATION; EMERGENCY. us/states/ky Kentucky General Assembly 2026RS SB 77 Kentucky SB 77 (2026RS)
bill
Agriculture
Appropriations
Budget And Financial Administration
Drugs And Medicines
Effective Dates
Emergency
Funds
Opioids
Public Health
State Agencies
enacted
A. Reed
D. Carroll
D. Douglas
L. Tichenor
S. Funke Frommeyer
S. Madon
S. Rawlings
3 35 4 2026-01-13T05:00:00+00:00 2026-04-14T04:00:00+00:00 openstates ocd-bill/0332a489-c847-4ae5-a711-5e4e6e0ddd72 https://apps.legislature.ky.gov/record/26RS/sb77.html d6056c03297c2ac4addf3c28a5f480757d251b21f5794cb90ba0031f88269a02 2026-07-01 https://data.openstates.org/daily/2026-07-01/public.pgdump 2026-07-06 reported
legislation
bill
us-ky

Kentucky SB 77 (2026RS) — AN ACT relating to ibogaine research in the Commonwealth.

Create new sections of KRS Chapter 218A to define terms; establish the ibogaine research and intellectual property fund to be administered by the Department of Agriculture for the purpose of allowing the department to enter a public-private partnership with a drug developer to conduct a clinical drug development trial or trials related to the use of ibogaine for the treatment of opioid use disorder, co-occurring substance use disorder, or any other neurological or mental health condition for which ibogaine demonstrates efficacy; establish requirements for the department related to how it contracts with a drug developer related to ibogaine research and intellectual property; appropriate $21 million from the opioid abatement trust fund to the ibogaine research and intellectual property development fund in fiscal year 2026-2027 and in fiscal year 2027-2028; APPROPRIATION; EMERGENCY.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

  1. Introduced (filed) — source
  2. Acts Chapter 158 (committee substitute) — source
  3. Current/Final (committee substitute) — source

Votes

  • Pass — 82–8 (pass) · upper
  • Veto Override — 77–18 (pass) · upper
  • PASS SB 77 w/ SCS 1, SCA 1 (T) — 35–2 (pass) · upper
  • OVERRIDE VETO FINAL PASSAGE SB 77 — 31–6 (pass) · upper

Sponsors

  • A. Reed — primary (person)
  • D. Carroll — primary (person)
  • D. Douglas — primary (person)
  • L. Tichenor — primary (person)
  • S. Funke Frommeyer — primary (person)
  • S. Madon — primary (person)
  • S. Rawlings — primary (person)

Timeline

The legislative action history — every referral, reading, and vote.

  • 2026-01-13T05:00:00+00:00 introduced in Senate introduction
  • 2026-01-13T05:00:00+00:00 to Committee on Committees (S) referral-committee
  • 2026-03-09T04:00:00+00:00 to Health Services (S) referral-committee
  • 2026-03-11T04:00:00+00:00 reported favorably, 1st reading, to Calendar with Committee Substitute (1) and Committee Amendment (1-title) committee-passage
  • 2026-03-12T04:00:00+00:00 2nd reading, to Rules reading-2
  • 2026-03-12T04:00:00+00:00 posted for passage in the Regular Orders of the Day for Friday, March 13 2026
  • 2026-03-13T04:00:00+00:00 3rd reading, passed 35-2 with Committee Substitute (1) and Committee Amendment (1-title) passage, reading-3
  • 2026-03-17T04:00:00+00:00 received in House
  • 2026-03-17T04:00:00+00:00 to Committee on Committees (H) referral-committee
  • 2026-03-20T04:00:00+00:00 to Veterans, Military Affairs, & Public Protection (H) referral-committee
  • 2026-03-24T04:00:00+00:00 reported favorably, 1st reading, to Calendar committee-passage
  • 2026-03-25T04:00:00+00:00 2nd reading, to Rules reading-2
  • 2026-04-01T04:00:00+00:00 taken from Rules
  • 2026-04-01T04:00:00+00:00 placed in the Orders of the Day
  • 2026-04-01T04:00:00+00:00 3rd reading, passed 82-8 passage, reading-3
  • 2026-04-01T04:00:00+00:00 received in Senate
  • 2026-04-01T04:00:00+00:00 enrolled, signed by President of the Senate passage
  • 2026-04-01T04:00:00+00:00 enrolled, signed by Speaker of the House passage
  • 2026-04-01T04:00:00+00:00 delivered to Governor
  • 2026-04-13T04:00:00+00:00 Vetoed executive-veto
  • 2026-04-14T04:00:00+00:00 received in Senate
  • 2026-04-14T04:00:00+00:00 to Rules (S) referral-committee
  • 2026-04-14T04:00:00+00:00 posted for passage for consideration of Governor's veto
  • 2026-04-14T04:00:00+00:00 veto overridden veto-override-passage
  • 2026-04-14T04:00:00+00:00 passed 31-6 passage
  • 2026-04-14T04:00:00+00:00 received in House
  • 2026-04-14T04:00:00+00:00 to Rules (H) referral-committee
  • 2026-04-14T04:00:00+00:00 taken from Rules (H)
  • 2026-04-14T04:00:00+00:00 posted for consideration of Governor's veto
  • 2026-04-14T04:00:00+00:00 veto overridden veto-override-passage
  • 2026-04-14T04:00:00+00:00 passed 77-18 passage
  • 2026-04-14T04:00:00+00:00 received in Senate
  • 2026-04-14T04:00:00+00:00 enrolled, signed by President of the Senate passage
  • 2026-04-14T04:00:00+00:00 enrolled, signed by Speaker of the House passage
  • 2026-04-14T04:00:00+00:00 delivered to Secretary of State (Acts Ch. 158) became-law

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/0332a489-c847-4ae5-a711-5e4e6e0ddd72. Confidence: reported (aggregated from official Kentucky legislature records).

Reference in New Issue View Git Blame Copy Permalink